MDGL: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/ebbfb01d-ac42-4382-b9f1-84532f9ef444/","filing_uuid":"ebbfb01d-ac42-4382-b9f1-84532f9ef444","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/ebbfb01d-ac42-4382-b9f1-84532f9ef444/print/","filing_document_content_type":"text/html","income":null,"expenses":"380000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brooke Mahady","dt_posted":"2026-07-20T16:10:20-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1001 Conshohocken State Road","registrant_address_2":"Suite 2-350","registrant_different_address":true,"registrant_city":"West Conshohocken","registrant_state":"PA","registrant_zip":"19428","registrant":{"id":401109961,"url":"https://lda.gov/api/v1/registrants/401109961/","house_registrant_id":77230,"name":"MADRIGAL PHARMACEUTICALS, INC.","description":null,"address_1":"1001 Conshohocken State Road","address_2":"Suite 2-350","address_3":null,"address_4":null,"city":"West Conshohocken","state":"PA","state_display":"Pennsylvania","zip":"19428","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BROOKE MAHADY","contact_telephone":"+1 267-355-5512","dt_updated":"2026-10-15T16:16:58.765395-04:00"},"client":{"id":69058,"url":"https://lda.gov/api/v1/clients/69058/","client_id":69058,"name":"MADRIGAL PHARMACEUTICALS, INC.","general_description":"Biopharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-09-08"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to CMMI drug pricing; 340B drug pricing","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152916,"prefix":"ms","prefix_display":"MS.","first_name":"ANGELA","nickname":null,"middle_name":"WALKER","last_name":"RIEMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Most Favored Nation drug pricing; Issues related to CMMI drug pricing","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152916,"prefix":"ms","prefix_display":"MS.","first_name":"ANGELA","nickname":null,"middle_name":"WALKER","last_name":"RIEMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}